BioSpaceOriginal article
FDA disavows Makary, Prasad’s papers as lawmaker blasts ‘shoot-from-the-hip’ policymaking
RegulatoryNegative
AI Analysis
Summary
FDA acting director Kyle Diamantas disavowed journal publications by Makary and Prasad in a letter to House lawmakers, stating they do not represent FDA policy or regulatory interpretation. The action follows criticism from lawmakers regarding FDA policymaking processes.
Outcome Details
FDA disavows journal publications by Makary and Prasad as not communicating FDA policy or regulatory interpretation
Importance:3/10
Sentiment:
-0.50
FDAregulatory policypolicymakingjournal publicationsHouse oversight
Read the original article
Published by BioSpace on July 17, 2026 11:13 AM